课题基金 / 基金详情

Evaluate, validate and refine the first clinical care pathway to risk-stratify patients with alcohol-related liver disease

Evaluate, validate and refine the first clinical care pathway to risk-stratify patients with alcohol-related liver disease
评估、验证和完善第一个临床护理途径，对酒精相关肝病患者进行风险分层
批准号：
470000
负责人：
Shaheen Abdel-Aziz M
金额：
$33.16万
依托单位：
University of Calgary
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2022
资助国家：
加拿大
项目状态：
未结题
起止时间：
2022-09-01 至 2026-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=470000&lang=en
关键词：
Clinical Care Pathway Clinical Decision Support Tool Primary Care

项目摘要

项目成果

Shaheen Abdel-Aziz M的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Approximately 1 in 4 Canadians is practicing high-risk alcohol drinking (more than 10 drinks a week for women and 15 drinks a week for men) based on the Canadian guidelines. One in 3 people who practice high-risk alcohol consumption, also known as heavy a
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Understanding and Responding to the COVID-19 Pandemic Effect on the Magnitude of Alcohol-Related Liver Disease in Alberta.
  • 批准号：
    460228
  • 项目类别：
    Operating Grants
  • 资助金额：
    $30.81万
  • 财政年份：
    2021
  • 负责人：
    Shaheen Abdel-Aziz M
  • 依托单位：
    University of Calgary
Developing and validating NAFLD advanced fibrosis diagnostic prediction model in primary care
  • 批准号：
    402930
  • 项目类别：
    Operating Grants
  • 资助金额：
    $19.84万
  • 财政年份：
    2019
  • 负责人：
    Shaheen Abdel-Aziz M
  • 依托单位：
    University of Calgary
海外基金